• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Key Steps Toward Launching XRP Spot ETFs: CBOE BZX Filings

user avatar

by Giorgi Kostiuk

9 months ago


CBOE BZX Exchange has filed 19b-4 documents with the SEC, which could pave the way for launching the first XRP-based spot ETFs in the US.

What is a 19b-4 Filing?

A 19b-4 filing is an official request to change a rule with the SEC, allowing companies to propose new investment products such as ETFs. These filings indicate asset managers' intent to offer XRP-based ETFs.

The Four Asset Managers Involved

The filings are submitted by four major asset management firms: Bitwise, 21Shares, Canary Capital, and WisdomTree. Each of these companies had already submitted S-1 filings, the initial step in the ETF registration process, before the 19b-4 filings.

The SEC’s Changing Approach

Historically cautious about crypto ETFs, the SEC may be shifting its stance due to new leadership appointments, which could impact not just XRP but the broader crypto space, opening the doors to new ETF products.

While the 19b-4 filings are a positive sign, approval is not guaranteed. The SEC's decision will be crucial for both the future of XRP and the broader cryptocurrency market.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Crypto Derivatives Industry Faces Structural Critique

chest

A fresh bout of soulsearching has gripped the crypto derivatives industry as leading market participants argue that the market's structure is fundamentally flawed.

user avatarDavid Robinson

Bitcoin Hyper Revolutionizes Smart Contracts on Bitcoin

chest

Bitcoin Hyper aims to address Bitcoin's limitations by introducing a high-speed execution layer for smart contracts.

user avatarAndrew Smith

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.